<table width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 2: Drugs That May Decrease T<sub>4</sub> Absorption  (Hypothyroidism)</caption>
<col align="left" valign="top" width="30%"></col>
<col align="left" valign="top" width="70%"></col>
<thead>
<tr>
<th align="center" stylecode="Lrule Rrule">Drug or Drug Class</th>
<th align="center" stylecode="Rrule">Effect</th>
</tr>
</thead>
<tfoot>
<tr>
<td align="left" colspan="2">Potential impact: Concurrent use may reduce the efficacy of levothyroxine by binding and delaying or preventing absorption, potentially resulting in hypothyroidism.</td>
</tr>
</tfoot>
<tbody>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Calcium Carbonate<br/>Ferrous Sulfate</td>
<td stylecode="Rrule">Calcium carbonate may form an insoluble chelate with levothyroxine, and ferrous sulfate likely forms a ferric-thyroxine complex. Administer levothyroxine at least 4 hours apart from these agents.</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Orlistat</td>
<td stylecode="Rrule">Patients treated concomitantly with orlistat and levothyroxine should be monitored for changes in thyroid function.</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Bile Acid Sequestrants<br/>-Colesevelam<br/>-Cholestyramine<br/>-Colestipol<br/>Ion Exchange Resins<br/>-Kayexalate<br/>-Sevelamer</td>
<td stylecode="Rrule">Bile acid sequestrants and ion exchange resins are known to decrease levothyroxine absorption. Administer levothyroxine at least 4 hours prior to these drugs or monitor thyrotropin-stimulating hormone (TSH) levels.</td>
</tr>
<tr>
<td stylecode="Lrule Rrule">Other drugs:<br/>Sucralfate<br/>Antacids<br/>- Aluminum &amp; Magnesium Hydroxides<br/>- Simethicone</td>
<td stylecode="Rrule"></td>
</tr>
</tbody>
</table>